Because we saw only a small effect of everolimus on the proliferation of the ER- 8p11-p12 SUM-52 breast cancer cell line, we also wanted to test the effect of EIF4EBP1 knockdown on these cells. Here, EIF4EBP1 is linked to breast carcinoma.